3F VC

Want to know why Dropbox’s 2007 deck worked? Ask for a slide-by-slide breakdown, then click any cited slide and the real deck opens right on it. Answers you can actually check.

Your startup is probably leaving thousands in free credits on the table. Notion, Asana, Airtable, Atlassian, Freshworks: most tools have startup perks, and nobody tells you where they are. Ask once and get every offer with a link to the program page.

Early-stage founders in India: stop digging through 20 grant portals. Ask one question and get SISFS, NIDHI-PRAYAS, TIDE 2.0 and state schemes matched to your stage. Every answer links to the official source. Something we’ve been building with the Eklavya team 👇

What goes into building a SOTA biomolecule design model? We spoke with @anindyadeeps , founder of LiteFold, about LiteMol-1, their new model for designing different classes of biomolecules. The conversation covered sequence modelling, molecular representations, data quality and compute efficiency.

✈️Airports are capital-intensive platforms that combine a regulated core service with commercial rights over a larger customer wallet. Three lessons transfer well to early-stage founders building marketplaces, tools or concession-style businesses:

A ₹1,500 XY stage resolving sub-20 nm movement. Built as one monolithic 3D print, with 210 nm repeatable movement. F²R is making nanopositioning dramatically more accessible.

Open to medical, engineering and design students/professionals, as well as entrepreneurs and independent innovators. Pre-registration closes 9th August at 8 PM. Apply: forms.gle/He2bQJAcRvJasoVX8 If someone in your network should see this, please pass it along.

If you are building in medical devices, or know someone who wants to, this might be worth sending their way. M.I.C.E. Labs is hosting MEDHA 2026 with BETiC Labs, IIT Bombay.

Young founders and operators are often told to build in public. We are often culprits of saying that too. But the harder question is rarely answered: What do you actually post when you are early, confused, still learning, and building in public for the first time?

We’re happy to share that we’ve backed NeoVes. NeoVes is a stem-cell biotech startup researching better outcomes for neuropathy and nerve damage.